Universal Access to HIV Treatment versus Universal ‘Test and Treat’: Transmission, Drug Resistance & Treatment Costs

@inproceedings{Wagner2012UniversalAT,
  title={Universal Access to HIV Treatment versus Universal ‘Test and Treat’: Transmission, Drug Resistance & Treatment Costs},
  author={Bradley G. Wagner and Sally Blower},
  booktitle={PloS one},
  year={2012}
}
In South Africa (SA) universal access to treatment for HIV-infected individuals in need has yet to be achieved. Currently ~1 million receive treatment, but an additional 1.6 million are in need. It is being debated whether to use a universal 'test and treat' (T&T) strategy to try to eliminate HIV in SA; treatment reduces infectivity and hence transmission. Under a T&T strategy all HIV-infected individuals would receive treatment whether in need or not. This would require treating 5 million… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 27 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research • 2015
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Prevention of HIV-1 infection with early antiretroviral therapy.

The New England journal of medicine • 2011
View 2 Excerpts

Similar Papers

Loading similar papers…